PegBio Co., Ltd. (HKG:2565)
Hong Kong · Delayed Price · Currency is HKD 57.15
-1.65 (-2.81%)
At close: Mar 27, 2026
PegBio Market Cap
PegBio has a market cap or net worth of 22.35 billion as of March 27, 2026.
Market Cap
22.35B
Enterprise Value
21.87B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
57.15
Market Cap Chart
Since May 27, 2025, PegBio's market cap has increased from 4.46B to 22.35B, an increase of 400.96%. That is a compound annual growth rate of 592.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 22.35B | -17.17% |
| Dec 31, 2025 | 26.99B | 504.83% |
| May 27, 2025 | 4.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Junshi Biosciences | 35.08B |
| TransThera Sciences (Nanjing) | 27.89B |
| InnoCare Pharma | 26.41B |
| Duality Biotherapeutics | 25.62B |
| Genscript Biotech | 24.27B |
| Keymed Biosciences | 17.84B |
| Ascletis Pharma | 17.26B |
| Ascentage Pharma Group International | 15.74B |